跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 19,724 条关于
“MEK inhibitors”
全部
19,724
临床试验
11,464
药物
3,794
机构
61
资讯
4,405
去年
Pasithea Therapeutics Raises $6.3 Million to Advance MEK Inhibitor for Neurofibromatosis Type 1
9个月前
Pasithea Therapeutics Secures $60 Million Funding to Advance MEK Inhibitor for Neurofibromatosis Treatment
2个月前
Biomarker-Guided Drug Combinations May Overcome Treatment Resistance in Advanced Melanoma
2年前
Pasithea Therapeutics Initiates Phase 1 Trial of PAS-004, a Novel MEK Inhibitor, for Advanced Solid Tumors and NF1
去年
Pasithea's PAS-004 Shows Strong Target Engagement with 91% pERK Inhibition in Phase 1 Cancer Trial
去年
PAS-004 Shows Favorable Safety and Early Efficacy in MAPK-Driven Solid Tumors
去年
Verastem Oncology to Present New LGSOC Treatment Data at SGO 2025 Annual Meeting
去年
FDA Grants Fast Track Designation to Immuneering's IMM-1-104 for Advanced Melanoma
10个月前
Mirdametinib Achieves 87% Response Rate in Pediatric Low-Grade Glioma Phase 1/2 Trial
去年
Pasithea Therapeutics Expands PAS-004 Clinical Trial to Europe, Completes Dosing in Cohort 4A
第 1 页,共 441 页
上一页
下一页